Access to anti-retroviral drugs, female in Pre-demographic dividend
Pre-demographic dividend: Access to anti-retroviral drugs, female was 86.4% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Pre-demographic dividend, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Pre-demographic dividend stood at 86.4%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.0% on the previous year and up 89.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Pre-demographic dividend peaked at 86.4% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Pre-demographic dividend, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | +4785.3% |
| 2002 | 0.2% | +2278.2% |
| 2003 | 0.5% | +108.4% |
| 2004 | 1.8% | +255.1% |
| 2005 | 3.4% | +95.8% |
| 2006 | 6.2% | +79.0% |
| 2007 | 9.5% | +54.2% |
| 2008 | 13.8% | +45.5% |
| 2009 | 17.5% | +26.7% |
| 2010 | 21.7% | +24.2% |
| 2011 | 26.3% | +20.8% |
| 2012 | 32.6% | +24.0% |
| 2013 | 38.3% | +17.8% |
| 2014 | 45.5% | +18.7% |
| 2015 | 50.5% | +10.9% |
| 2016 | 56.5% | +11.9% |
| 2017 | 62.6% | +10.7% |
| 2018 | 64.6% | +3.3% |
| 2019 | 68.2% | +5.5% |
| 2020 | 72.3% | +6.0% |
| 2021 | 75.8% | +4.9% |
| 2022 | 79.6% | +5.0% |
| 2023 | 83.1% | +4.4% |
| 2024 | 86.4% | +4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.3% | 0.0% | 17.5% | 10 |
| 2010s | 46.7% | 21.7% | 68.2% | 10 |
| 2020s | 79.5% | 72.3% | 86.4% | 5 |
More gender data for Pre-demographic dividend
- Labor force, female 197.89 million (2025)
- Labor force, female, per capita 0.1746 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 3.08 % change on previous year (2025)
- Labor force, female, per square kilometre 9.27 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.7767 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.4232 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.935 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.3108 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 129.2% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Pre-demographic dividend?
- Access to anti-retroviral drugs, female in Pre-demographic dividend was 86.4% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Pre-demographic dividend?
- The highest recorded value was 86.4% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Pre-demographic dividend?
- The lowest recorded value was 0.0% in 2000.
- How does Pre-demographic dividend rank for access to anti-retroviral drugs, female?
- Pre-demographic dividend ranks 8th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Pre-demographic dividend?
- Over the last ten years it is up 89.9%. The long-run trend across the full record is volatile.
- Where does this Pre-demographic dividend data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.